Priothera
  • Home
  • About Us
    • Leadership Team
    • Functional Area Heads
    • Board of Directors
    • Advisory Board
    • Investors
    • ESG
  • Science
    • Mocravimod
    • Acute myeloid leukemia
    • Hematopoietic Cell Transplantation
    • Our Pipeline
    • CAR T cell therapy
    • Publications
    • Partners
  • MO-TRANS Phase 3 Study
  • News
    • Press Releases
    • In the news
    • Events
  • Contact Us
Select Page
LSX – Investival Showcase

LSX – Investival Showcase

by admin | Oct 10, 2024 | Events

Recent Posts

  • Priothera to Present Trial in Progress Poster for Mocravimod at 2024 American Society of Hematology (ASH) Annual Meeting
  • LMA : phase III et levée de fonds en cours pour Priothera
  • Booster l’efficacité des thérapies cellulaires
  • LSX – Investival Showcase
  • EUROAPI and Priothera enter into CDMO collaboration to advance oncology project

Recent Comments

    Contact Us

    Priothera Ltd

    88 Harcourt Street, Dublin 2,
    D02 DK18, Ireland

    Priothera SAS France

    57 Avenue Général de Gaulle
    68300 Saint-Louis, France

    

    © Priothera Ltd. 2023